Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102193 · ClinicalTrials.gov registry record · Phase 3
Study for the Treatment of Ulcerative Colitis With Adacolumn
A Phase 3 study, sponsored by Otsuka America Pharmaceutical.
- Completed
- Registry status
- Phase 3
- Development phase
- 168
- Enrollment target
NCT00102193: Completed Phase 3 study, sponsored by Otsuka America Pharmaceutical.
NCT00102193 is a Phase 3 study that has completed, run by Otsuka America Pharmaceutical. The registered enrollment target is 168 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00102193, a Phase 3 study, has completed, sponsored by Otsuka America Pharmaceutical.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 168 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and effectiveness of the Adacolumn Apheresis System to treat the signs and symptoms of ulcerative colitis.
Interventions
- DEVICE Adacolumn Apheresis System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2004-07 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
What the finished NCT00102193 record still lists
NCT00102193 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Adacolumn Apheresis System is the first listed.
NCT00102193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00102193 about?
NCT00102193 is a clinical study titled "Study for the Treatment of Ulcerative Colitis With Adacolumn". The purpose of this study is to demonstrate the safety and effectiveness of the Adacolumn Apheresis System to treat the signs and symptoms of ulcerative colitis.
What is the current status of trial NCT00102193?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 168 participants. The study started on 2004-07. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00102193?
The interventions under investigation include: Adacolumn Apheresis System (DEVICE).
Who is sponsoring clinical trial NCT00102193?
This trial is sponsored by Otsuka America Pharmaceutical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00102193's enrollment target sits among peer trials
168 1459th of 2000 higher than 538 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia